Clinical Trial Details
| Trial ID: | L3983 |
| Source ID: | NCT02077946 |
| Associated Drug: | Liraglutide |
| Title: | A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes|Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: liraglutide|DRUG: sitagliptin |
| Outcome Measures: | Primary: Percent (%) of patients achieving at least 1 %-point HbA1c (glycosylated haemoglobin) reduction, Day 0, Day 180 | Secondary: Percent (%) of patients with HbA1c (glycosylated haemoglobin) reduction at least 1 %-point and weight reduction at least 3% (NICE clinical guidelines, liraglutide only), Day 0, Day 180|HbA1c (NGSP standard, in %) change, Day 0, Day 180|Change in weight (in kilograms), Day 0, Day 180|Change in blood pressure (systolic, in mmHg), From baseline to 180 days of therapy|Change in lipids (HDL, LDL and triglycerides, in mmol/L), Day 0, Day 180|Change in creatinine, Day 0, Day 180 |
| Sponsor/Collaborators: | Sponsor: Novo Nordisk A/S |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 1059 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2014-02-10 |
| Completion Date: | 2014-09-03 |
| Results First Posted: | |
| Last Update Posted: | 2017-05-31 |
| Locations: | Novo Nordisk Investigational Site, Malmö, 202 15, Sweden |
| URL: | https://clinicaltrials.gov/show/NCT02077946 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|